Swimming’s world governing body FINA has strongly criticized the organizers of next year’s Olympics in Rio de Janeiro over what KENILWORTH, N.J. – Drugmaker Merck & Co. says its experimental Type 2 diabetes drug performed about as well as its older daily pill, Januvia, in a late-stage patient test.